MCD vs ZYME · P/E 23, rev $25.92B vs rev $76.3M
McDonald’s Corporation (MCD) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MCD and ZYME stock pages for the full models.
Not investment advice.